RNA editing study shows potential for more effective precision cancer treatment
Credit: MD Anderson Cancer Center If there is one thing all cancers have in common, it is they have nothing in common. A multi-center study...
Credit: MD Anderson Cancer Center If there is one thing all cancers have in common, it is they have nothing in common. A multi-center study...
Credit: Penn Medicine PHILADELPHIA - Penn Medicine researchers have used CRISPR/Cas9 gene editing technology to isolate a key genetic feature that could cause resistance to...
LUGANO, 26 April 2018 - ESMO, the leading professional organisation for medical oncology, shares concerns expressed in a scientific paper (1) and reflected in the...
Curious children are better able to grasp basic math and reading. This is according to a group of researchers from the University of Michigan, led...
Johns Hopkins researchers report success with a smart phone video-based app that substitutes for a daily in-person visit by a health care worker required for...
(Boston)--The average profile of an American using a gun for suicide is a married, white male over the age of 50 who is experiencing deteriorating...
A new study from City, University of London and MIT may have revealed the reasons behind our memory limitations. The researchers found that trying to...
© Monet, Fotolia Patients with meningococcal infection generally develop symptoms including a high temperature, vomiting and a stiff neck... but they might also just have...
Plants have provided a new avenue in curbing tumor growth. On this occasion, it doesn't involve miracle species or the like, but rather the results...
A study of nearly 6,000 Americans followed for 24 years from middle to late adulthood found that having chronic inflammation in middle age may be...
Credit: Russell McIntire, Jefferson (Philadelphia University + Thomas Jefferson University) (PHILADELPHIA) - To catch prostate cancer at earlier stages, when it's more easily treated, many...
NEW YORK (April 26, 2018) - Probiotics may be a relatively safe, simple, and low-cost solution for preventing Clostridium difficile infections (CDI) in hospital settings,...
LOS ANGELES - In March 2017, the U.S. Food and Drug Administration approved ocrelizumab as the first treatment for both relapsing (RMS) and progressive forms...
Credit: Nick Romanenko/Rutgers University About 21 million years ago, a fungus that causes a devastating disease in rice first became harmful to the food that...
The new finding published today in Pediatric Anesthesia, is based on a data-linkage study of over 210,000 children in New South Wales, Australia. The 211,978...
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.